PROTECT VIII Kids: BAY 94-9027 (PEGylated Recombinant Factor VIII) safety and efficacy in previously treated children with severe haemophilia A

E. Santagostino, G. Kenet, K. Fischer, T. Biss, S. Ahuja, M. Steele

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e55-e65
JournalHaemophilia
Volume26
Issue number3
DOIs
Publication statusPublished - 2020

Keywords

  • children
  • factor VIII
  • haemophilia A
  • polyethylene glycol
  • prophylaxis

Cite this